Table A7.
Assay | Reagent | Description | Heparin Neutralization |
---|---|---|---|
IN-test | Ellagic acid | Intrinsic pathway screening test | No |
HI-test | Ellagic acid + Heparinase | Intrinsic pathway screening test with heparinase | Yes |
EX-test | Recombinant tissue factor + Polybrene | Rapid overview of the coagulation process | Yes |
AP-test | Tissue factor + Aprotinin + Polybrene | Exploration of the fibrinolysis by comparison with the EX-test results | Yes |
tPA-test | Recombinant tissue factor + Recombinant tPA + Polybrene | Exploration of the fibrinolysis by comparison with the EX-test results | Yes |
FIB-test | Recombinant tissue factor + Cytolochalasin D + Abciximab + Polybrene | Functional detection of the fibrinogen level after dual platelet inhibition by cytochalasin D and abciximab | Yes |
RVV-test | Reagent derived from Russell viper venom | Detection of factor Xa inhibitors (LMWH, DOAC) | No |
ECA-test | Ecarin + Polybrene | Detection of direct thrombin antagonists | Yes |
NA-test | None | Non-activated test for the exploration of non-activated coagulation in citrated blood | No |
Abbreviations: LMWH: Low molecular weight heparin; UFH: unfractionated heparin; DOAC: Direct oral anticoagulant.